🚀 VC round data is live in beta, check it out!
- Public Comps
- U.S. Physical Therapy
U.S. Physical Therapy Valuation Multiples
Discover revenue and EBITDA valuation multiples for U.S. Physical Therapy and similar public comparables like Indegene, B-Soft Co., Netcare, Astrana Health and more.
U.S. Physical Therapy Overview
About U.S. Physical Therapy
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Founded
1990
HQ

Employees
7.0K
Website
Financials (LTM)
EV
$2B
U.S. Physical Therapy Financials
U.S. Physical Therapy reported last 12-month revenue of $791M and EBITDA of $97M.
In the same LTM period, U.S. Physical Therapy generated $97M in EBITDA and $41M in net income.
Revenue (LTM)
U.S. Physical Therapy P&L
In the most recent fiscal year, U.S. Physical Therapy reported revenue of $781M and EBITDA of $110M.
U.S. Physical Therapy expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $791M | XXX | $781M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $150M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA | $97M | XXX | $110M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $41M | XXX | $40M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $127M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
U.S. Physical Therapy's stock price is $83.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 0.0% | XXX | XXX | XXX | $2.63 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialU.S. Physical Therapy Valuation Multiples
U.S. Physical Therapy trades at 1.9x EV/Revenue multiple, and 15.9x EV/EBITDA.
EV / Revenue (LTM)
U.S. Physical Therapy Financial Valuation Multiples
As of March 7, 2026, U.S. Physical Therapy has market cap of $1B and EV of $2B.
Equity research analysts estimate U.S. Physical Therapy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
U.S. Physical Therapy has a P/E ratio of 30.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 15.9x | XXX | 14.0x | XXX | XXX | XXX |
| EV/EBIT | 18.4x | XXX | 18.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 10.3x | XXX | XXX | XXX |
| P/E | 30.8x | XXX | 31.6x | XXX | XXX | XXX |
| EV/FCF | 24.3x | XXX | 25.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified U.S. Physical Therapy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


U.S. Physical Therapy Margins & Growth Rates
U.S. Physical Therapy's revenue in the last 12 month grew by 7%.
U.S. Physical Therapy's revenue per employee in the last FY averaged $0.1M.
U.S. Physical Therapy's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
U.S. Physical Therapy's rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
U.S. Physical Therapy Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | (5%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 30% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
U.S. Physical Therapy Public Comps
See public comps and valuation multiples for other Hospitals & Clinics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Indegene | XXX | XXX | XXX | XXX | XXX | XXX |
| B-Soft Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Netcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Astrana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Thomson Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
U.S. Physical Therapy M&A Activity
U.S. Physical Therapy acquired XXX companies to date.
Last acquisition by U.S. Physical Therapy was on XXXXXXXX, XXXXX. U.S. Physical Therapy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by U.S. Physical Therapy
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialU.S. Physical Therapy Investment Activity
U.S. Physical Therapy invested in XXX companies to date.
U.S. Physical Therapy made its latest investment on XXXXXXXX, XXXXX. U.S. Physical Therapy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by U.S. Physical Therapy
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout U.S. Physical Therapy
| When was U.S. Physical Therapy founded? | U.S. Physical Therapy was founded in 1990. |
| Where is U.S. Physical Therapy headquartered? | U.S. Physical Therapy is headquartered in United States. |
| How many employees does U.S. Physical Therapy have? | As of today, U.S. Physical Therapy has over 7K employees. |
| Who is the CEO of U.S. Physical Therapy? | U.S. Physical Therapy's CEO is Christopher J. Reading. |
| Is U.S. Physical Therapy publicly listed? | Yes, U.S. Physical Therapy is a public company listed on NYSE. |
| What is the stock symbol of U.S. Physical Therapy? | U.S. Physical Therapy trades under USPH ticker. |
| When did U.S. Physical Therapy go public? | U.S. Physical Therapy went public in 1992. |
| Who are competitors of U.S. Physical Therapy? | U.S. Physical Therapy main competitors are Indegene, B-Soft Co., Netcare, Astrana Health. |
| What is the current market cap of U.S. Physical Therapy? | U.S. Physical Therapy's current market cap is $1B. |
| What is the current revenue of U.S. Physical Therapy? | U.S. Physical Therapy's last 12 months revenue is $791M. |
| What is the current revenue growth of U.S. Physical Therapy? | U.S. Physical Therapy revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of U.S. Physical Therapy? | Current revenue multiple of U.S. Physical Therapy is 1.9x. |
| Is U.S. Physical Therapy profitable? | Yes, U.S. Physical Therapy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of U.S. Physical Therapy? | U.S. Physical Therapy's last 12 months EBITDA is $97M. |
| What is U.S. Physical Therapy's EBITDA margin? | U.S. Physical Therapy's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of U.S. Physical Therapy? | Current EBITDA multiple of U.S. Physical Therapy is 15.9x. |
| What is the current FCF of U.S. Physical Therapy? | U.S. Physical Therapy's last 12 months FCF is $63M. |
| What is U.S. Physical Therapy's FCF margin? | U.S. Physical Therapy's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of U.S. Physical Therapy? | Current FCF multiple of U.S. Physical Therapy is 24.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.